中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 7
Jul.  2016

Clinical features of HIV/AIDS patients with digestive diseases

DOI: 10.3969/j.issn.1001-5256.2016.07.037
  • Published Date: 2016-07-20
  • Objective To analyze the clinical data of patients admitted with an initial diagnosis of digestive diseases who have human immunodeficiency virus( HIV) / acquired immune deficiency syndrome( AIDS),and to guide clinical diagnosis. Methods The clinical data of HIV / AIDS patients who were hospitalized due to digestive system symptoms from January 1,2013 to December 31,2014 were collected,including epidemiological data,clinical symptoms and signs,auxiliary examinations,and complications. The features of each parameter were observed. The t- test was used for comparison of continuous data between groups,and the chi- square test was used for comparison of categorical data between groups. Results A total of 95 HIV / AIDS patients with digestive diseases were enrolled,and the male / female ratio was1. 4∶ 1. Among these patients,57( 60%) were aged 30- 50 years,85( 89. 47%) were Yi people,and 86( 90. 53%) were farmers. Of all patients,46( 48. 42%) were infected via sexual transmission and 44( 46. 32%) were infected via intravenous drug use. In these patients,common clinical symptoms included abdominal pain( 71. 58%),pyrexia( 43. 16%),and diarrhea( 17. 89%),and common signs included ascites( 28. 42%),superficial lymphadenectasis( 21. 05%),and hepatosplenomegaly( 16. 84%). The auxiliary examination showed a significant increase in globulin. The proportion of patients with opportunistic infection reached 83. 16%,mainly lung and digestive tract infections. Among the patients who underwent gastroscopy,31. 58% had mycotic esophagitis. Chronic non- atrophic gastritis,electrolyte disturbance,and intestinal obstruction were commonly seen in patients with noninfectious complications. Of all HIV / AIDS patients,54. 74%( 52 /95) were complicated by HBV and / or HCV infection,and the liver function parameters globulin,total bilirubin,aspartate aminotransferase,alanine aminotransferase,and A / G showed significant differences between these patients and the patients with HIV infection alone( all P < 0. 01). Conclusion HIV infection should be highly suspected in patients who visit the department of gastroenterology due to abdominal pain and diarrhea,have clinical manifestations of ascites,superficial lymphadenectasis,and hepatosplenomegaly,and are complicated by opportunistic infection in the lungs and digestive tract,especially those with histories of drug use and unprotected sex. Meanwhile,HBV and / or HCV infection may aggravate patients' condition and should be taken seriously.

     

  • [1]KANG WF,JIANG JX.Research advances in association between HIV infection and intestinal immune system[J].The J Pract Med,2013,29(6):1007-1009.(in Chinese)康伟芳,蒋就喜.HIV感染与肠道免疫系统关系的研究进展[J].实用医学杂志,2013,29(6):1007-1009.
    [2]LI HY,WU H.Advances in pathogenesis of HIV[J].J Pathog Biol,2008,3(3):217-230.(in Chinese)李海英,吴昊.HIV致病机制研究进展[J].中国病原生物学杂志,2008,3(3):217-230.
    [3]National Standard of the People's Republic of China by State Bureau of Technical Supervision.Diagnostic criteria and principles of management of HIV/AIDS:GB 16000-1995[S].Chin J Prevent Control STD AIDS,1998,4(2):85-87.(in Chinese)国家技术监督局中华人民共和国国家标准.HIV/AIDS诊断标准及处理原则:GB 16000-1995[S].中国性病艾滋病防治,1998,4(2):85-87.
    [4]ZHU YX,GONG YH,WANG QX,et al.AIDS surveillance in injecting drug users in Liangshan,Sichuan,2010-2013[J].Dis Surveill,2015,30(5):395-398.(in Chinese)朱言蹊,龚煜汉,王启兴,等.2010-2013年四川省凉山州吸毒人群艾滋病监测分析[J].疾病监测,2015,30(5):395-398.
    [5]WANG QX,GONG YH,NAN L,et al.Analysis on the results of sampling survey for HIV infection among rural population in 14counties of Liangshan prefecture[J].Modern Prevent Med,2015,42(2):328-331,350.(in Chinese)王启兴,龚煜汉,南磊,等.凉山州14县农村地区人群的艾滋病抗体抽样调查结果分析[J].现代预防医学,2015,42(2):328-331,350.
    [6]LAWN SD,BUTERA ST,FOLKS TM.Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection[J].Clin Microbiol Rev,2001,14(4):753-777.
    [7]LU LG,LI ZH.Diagnosis and assessment of liver cirrhosis[J].JClin Hepatol,2014,30(7):577-579.(in Chinese)陆伦根,李郑红.肝硬化的诊断和评估[J].临床肝胆病杂志,2014,30(7):577-579.
    [8]WANG HP,YANG JJ,DENG XZ,et al.HIV/HBV/HCV infection among drug users:a meta analysis of data collected in Chinese mainland[J].Chin J Dis Control Prev,2010,14(4):300-304.(in Chinese)王昊鹏,杨静静,邓小昭,等.中国大陆吸毒人群HIV、HBV、HCV感染状况及其相关因素的Meta分析[J].中华疾病控制杂志,2010,14(4):300-304.
    [9]ZHAO W,YAO XA,TANG YB,et al.An analysis of patients with HIV infection complicated by HBV and HCV infection[J].Guangdong Med J,2010,31(1):79-81.(in Chinese)赵稳,姚细安,唐漾波,等.HIV感染者合并HBV及HCV感染情况分析[J].广东医学,2010,31(1):79-81.
    [10]WEI DY,MA MJ,GONG YH,et al.A survey of HIV/HBV/HCVinfection in drug users[J].J Prevent Med Inf,2000,16(2):187.(in Chinese)卫大英,马名驹,龚煜汉,等.吸毒人群中HIV/HBV/HCV感染调查[J].预防医学情报杂志,2000,16(2):187.
    [11]SU L,QIN GM,HUANG J,et al.Molecular epidemiology of HCVin HIV/HCV co-infection patients in Liangshan Prefecture[J].JPrevent Med Inf,2013,29(7):548-552.(in Chinese)苏玲,秦光明,黄俊,等.凉山州HIV/HCV共感染人群中HCV分子流行病学研究[J].预防医学情报杂志,2013,29(7):548-552.
    [12]ZHANG XL.Epidemiological characteristics and clinical features on HIV co-infection with HBV and/or HCV[D].Kunming:Kunming Med Univ,2013.张小丽.HIV/AIDS合并HBV/HCV感染的流行病学特征及临床特点[D].昆明:昆明医科大学,2013.
    [13]DONG PL,ZHANG K,WU H,et al.Clinical study on the interaction of human immunodeficiency virus and hepatitis C virus infected via blood in 140 adults[J].Clin Focus,2004,19(2):61-63.(in Chinese)董培玲,张可,吴昊,等.140例成人人类免疫缺陷病毒感染与丙型肝炎病毒感染相互影响[J].临床荟萃,2004,19(2):61-63.
    [14]ZHANG H.XIONG Y,GAO SC,et al.Clinical analysis on the 57AIDS patients complicated with central nervous system lesions[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2015,9(2):201-205.(in Chinese)张红,熊勇,高世成,等.艾滋病合并中枢神经系统病变的临床分析[J/CD].中华实验和临床感染病杂志:电子版,2015,9(2):201-205.
    [15]XIAOCHI SX,et al.Pathological changes of the digestive tract in patients with AIDS[J].YAO ZG,YAO Z.Progr Japanese Med,1994,15(2):58.(in Chinese)小池盛雄等.艾滋病的消化道病变病理所见[J].姚宗歌,姚桢,译.日本医学介绍,1994,15(2):58.
    [16]ZHONG HB,CHEN CX.The pathogenesis of gastrointestinal tract infected with HIV[J].Inter J Epidemiol Infect Dis,2006,33(6):385-388.(in Chinese)钟海兵,陈春晓.HIV感染消化道的发病机制[J].国际流行病学传染病学杂志,2006,33(6):385-388.
    [17]LIU L,SUN LG,WANG QQ,et al.Endoscopic and clinical features of acquired immunodeficiency syndrome complicated with fungal esophagitis[J].Chin J Nosocomiol,2014,24(5):1186-1188.(in Chinese)刘玲,孙乐刚,王秋芹,等.获得性免疫缺陷综合征患者真菌性食管炎的内镜表现及临床分析[J].中华医院感染学杂志,2014,24(5):1186-1188.
    [18]CLASTER S.Biology of anemia,differential diagnosis,and treatment options in human immunodeficiency virus infection[J].J Infect Dis,2002,185(Suppl 2):s105-s109.
    [19]VOLBERDING P.Consensus statement:anemia in HIV infection---current trends,treatment options,and practice strategies.Anemia in HIV Working Group[J].Clin Ther,2002,22(9):1004-1020.
    [20]SONG HY,SUN CG.Abnormal red blood cells and hepatitis B virus-associated liver disease[J].J Clin Hepatol,2004,20(6):377-379.(in Chinese)宋怀宇,孙成刚.红细胞异常与乙肝病毒相关性肝病[J].临床肝胆病杂志,2004,20(6):377-379.
    [21]TAN L,YANG J,XIE Y.The clinical study of anemia among HIV/AIDS patients[J].J Kunming Med Univ,2009,30(2):86-89.(in Chinese)谭琳,杨坚,谢瑜.HIV/AIDS患者并发贫血的临床分析[J].昆明医学院学报,2009,30(2):86-89.
  • Relative Articles

    [1]Zexin HU, Jintao HUANG, Binyan ZHONG, Jian SHEN, Xiaoli ZHU. Current status and prospects of transarterial chemoembolization and its combined regimens in the treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(1): 175-180. doi: 10.12449/JCH240129
    [2]Wencong DAI, Mengya ZANG, Guosheng YUAN, Qi LI, Rong LI, Wenli LI, Shuyu DONG, Jinzhang CHEN. Efficacy of hepatic arterial infusion chemotherapy and its multimodality therapeutic regimens in treatment of patients with advanced hepatocellular carcinoma and related prognostic factors[J]. Journal of Clinical Hepatology, 2023, 39(7): 1592-1599. doi: 10.3969/j.issn.1001-5256.2023.07.013
    [3]Xiufeng LIU, Jue ZHANG, Lin YAO, Chaoxu YANG. Advances in targeted therapy combined with immunotherapy for advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(5): 992-997. doi: 10.3969/j.issn.1001-5256.2022.05.004
    [4]Sirou LI, Yuanlong ZHOU, Keliang LIU, Zhibo LIANG, Jinghua LI. Conversion therapy for massive hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2022, 38(7): 1612-1615. doi: 10.3969/j.issn.1001-5256.2022.07.028
    [5]Kailing XIE, Feng XU. Mechanism of action of Huaier granules in treatment of hepatocellular carcinoma and advances in its clinical application[J]. Journal of Clinical Hepatology, 2022, 38(3): 676-681. doi: 10.3969/j.issn.1001-5256.2022.03.038
    [6]Mengkui HAN, Jin LI, Xiaohua YANG. Function and regulatory mechanism of T lymphocytes in tumor immune microenvironment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2621-2626. doi: 10.3969/j.issn.1001-5256.2022.11.037
    [7]Zhiyuan HOU, Yuan LIU, Chaoran YANG, Jisen ZHAO, Shujie CHENG. Current research status and prospect of circulating tumor DNA in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2616-2620. doi: 10.3969/j.issn.1001-5256.2022.11.036
    [8]Zhiyuan YU, Shiyu YANG, Jiaqi LI, Yan SUN. Current developmental status of non-surgical treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(5): 1205-1207. doi: 10.3969/j.issn.1001-5256.2021.05.048
    [9]Tianle GONG, Ping YUE, Jun YAN, Xun LI. Adjuvant therapies after surgery for hepatocellular carcinoma with microvascular invasion[J]. Journal of Clinical Hepatology, 2021, 37(3): 685-688. doi: 10.3969/j.issn.1001-5256.2021.03.037
    [10]Guoxiang CHEN, Mo ZHOU, Sheng CHEN, Yuan WANG, Yuanlong ZHOU, Jihong YANG. Mechanism of action of non-coding RNA in sorafenib resistance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(3): 699-703. doi: 10.3969/j.issn.1001-5256.2021.03.040
    [11]Shisi LI, Zhitang GUO, Zhangbin CHEN, Yishan TENG. Research advances in systemic therapy for advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(12): 2943-2946. doi: 10.3969/j.issn.1001-5256.2021.12.044
    [12]Yanmei ZOU, Xianglin YUAN. Application value of immunotherapy in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(8): 1758-1760. doi: 10.3969/j.issn.1001-5256.2021.08.004
    [13]Ningning ZHANG, Wei LU. Targeted therapy for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(8): 1753-1757. doi: 10.3969/j.issn.1001-5256.2021.08.003
    [14]Wang XiaoYun, Li LinFeng, Guo Quan, Ceng YiLan, Li HaiYang, Du YingRong, Chen Gang, Liang YueDong, Lu YinYing. Development and enlightenment of intelligentized diagnostic and therapeutic mode for hepatobiliary tumors[J]. Journal of Clinical Hepatology, 2019, 35(10): 2360-2364. doi: 10.3969/j.issn.1001-5256.2019.10.051
    [15]Shang ZhiYin, Yang JingMao, Chen LiPing, Liu Min, Cheng Kai, Li YaoHua, Ai YingChun, Cheng JiLin. Changes in gastrointestinal structure and function caused by cirrhotic portal hypertension and related clinical manifestations[J]. Journal of Clinical Hepatology, 2017, 33(2): 354-358. doi: 10.3969/j.issn.1001-5256.2017.02.034
    [16]Xu ZhengGuo, Zhao YongBing, Zheng YuanYu, Liu En, Yang ShiMing. Association between portal vein pressure drop gradient after transjugular intrahepatic portosystemic shunt and clinical prognosis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2016.12.019
    [17]Shi XiaoJu, Lyu GuoYue, Zhang Ping, Du XiaoHong, Wang GuangYi. Postoperative application of multidisciplinary treatment in patients with hepatobiliary and pancreatic malignancies[J]. Journal of Clinical Hepatology, 2015, 31(11): 1886-1888. doi: 10.3969/j.issn.1001-5256.2015.11.028
    [18]Society of Liver Cancer, Guangdong Provincial Anti-cancer Association. Strategy and method of multi-disciplinary comprehensive treatment of liver cancer-consensus of experts in Guangdong, China (2)[J]. Journal of Clinical Hepatology, 2014, 30(11): 1116-1119. doi: 10.3969/j.issn.1001-5256.2014.11.005
    [19]Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001
    [20]Wang JiYao. Importance of detecting portal hypertension in liver cirrhosis patients: theory, research tools, and clinical applications[J]. Journal of Clinical Hepatology, 2012, 28(9): 642-643.
  • Cited by

    Periodical cited type(20)

    1. 秦鹏,李树森,刘皓,吴广迎. 胃冠状静脉栓塞术在门脉高压性上消化道出血经颈静脉肝内门腔静脉分流术患者中的临床疗效. 血管与腔内血管外科杂志. 2022(09): 1130-1134 .
    2. 高绍,王宏亮,聂春晖,张岳林,周坦洋,余子牛,杨月,孙军辉. 对比TIPS联合胃冠状静脉栓塞术与单独TIPS治疗肝硬化门静脉高压伴上消化道出血的中远期疗效:Meta分析. 中国介入影像与治疗学. 2022(11): 673-677 .
    3. 张大维,吴东辉,孙兴安. TIPS对肝硬化并发上消化道出血患者近期肝肾功能和远期疗效的影响. 当代医学. 2021(35): 129-130 .
    4. 林纲毅,马洺远,蔡宗洋. 超声引导下门静脉穿刺导引经颈静脉肝内门体分流术联合曲张静脉栓塞治疗食管胃底静脉曲张破裂出血的临床效果. 中国当代医药. 2020(07): 113-116 .
    5. 王宁,林芳明,吕明. TIPS联合GCVE用于门静脉高压并发上消化道大出血的应用价值. 肝脏. 2020(09): 952-954 .
    6. 韩志强. 肝硬化上消化道出血37例外科临床治疗效果观察. 世界最新医学信息文摘. 2019(05): 95+102 .
    7. 张明礼. PTVE联合PSE治疗肝硬化门脉高压并上消化道出血的观察. 实用中西医结合临床. 2019(05): 24-26 .
    8. 孙允涛. 肝硬化门静脉高压并发上消化道出血的相关危险因素分析. 中国民康医学. 2019(10): 81-83 .
    9. 孙巧玉,赖雪珍,河源媛. 门脉高压合并上消化道出血采用PTVE联合PSE手术的效果分析. 现代消化及介入诊疗. 2019(08): 837-841+846 .
    10. 杨荣焕. TIPS和PTVE介入方法治疗肝硬化门静脉高压引起的上消化道出血的优劣差异. 黑龙江医学. 2019(09): 1012-1013+1016 .
    11. 武和平. 不同介入途径胃冠状静脉栓塞术治疗肝硬化门静脉高压出血的临床疗效观察. 现代消化及介入诊疗. 2018(02): 208-210 .
    12. 李广忠. 分析肝硬化门脉高压症下食管静脉曲张破裂出血的危险因素. 智慧健康. 2018(07): 91-92+126 .
    13. 李贤圣,董勤勇,张乐,夏侨,贺军. 经颈静脉门静脉分流术介入治疗门静脉高压引起上消化道出血的疗效分析. 浙江创伤外科. 2018(02): 272-273 .
    14. 赵晓飞,林栋栋,李宁,臧运金,郭庆良,武聚山. 门静脉高压患者脾切断流术后曲张静脉再出血的危险因素分析. 临床肝胆病杂志. 2018(10): 2182-2185 . 本站查看
    15. 吴笋. 经颈静脉肝内门体静脉分流术加胃冠状静脉栓塞术治疗门脉高压症初探. 现代医用影像学. 2018(05): 1522-1523+1528 .
    16. 田广俊,池晓玲,常钢,孟凡喆,曹敏玲,黎英贤,徐浩祥,梁宏才,赵朋涛,吴晓菊,萧焕明. 中药灌肠防治TIPS治疗肝硬化门静脉高压伴上消化道出血术后肝性脑病临床观察. 新中医. 2018(12): 87-91 .
    17. 樊春燕,叶晓丽,戴晓婷,吴宇清. 肝硬化门静脉高压并发上消化道出血的相关性分析研究. 血管与腔内血管外科杂志. 2018(05): 381-385 .
    18. 彭虹. 肝硬化门静脉高压并发上消化道出血的相关危险因素分析. 中国继续医学教育. 2017(31): 58-59 .
    19. 张志勇. 不同手术方案治疗肝硬化门脉高压症的临床对比. 临床医药文献电子杂志. 2017(46): 8924-8925 .
    20. 向平,张川,张亮科,唐瑞强,叶继彬. 1例上消化道出血病人护理体会. 世界最新医学信息文摘. 2016(14): 247 .

    Other cited types(3)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1946) PDF downloads(433) Cited by(23)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return